• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by CME Group Inc.

    3/5/26 1:24:32 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance
    Get the next $CME alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 9)


    CME Group Inc

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)




    02/27/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP Number(s):


    1Names of Reporting Persons

    The Vanguard Group
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    PENNSYLVANIA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    3,697,661.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    36,248,559.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    36,248,559.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    10.10 %
    12Type of Reporting Person (See Instructions)

    IA

    Comment for Type of Reporting Person:   On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. As of that date, The Vanguard Group, Inc. no longer performs portfolio management services or administers proxy voting. In accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. anticipates that certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that currently have, or are deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    CME Group Inc
    (b)Address of issuer's principal executive offices:

    20 South Wacker Drive, Chicago, IL, 60606
    Item 2. 
    (a)Name of person filing:

    The Vanguard Group
    (b)Address or principal business office or, if none, residence:

    100 Vanguard Blvd., Malvern, PA 19355
    (c)Citizenship:

    PA
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    12572Q105
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    36248559
    (b)Percent of class:

    10.1  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    3697661

     (iii) Sole power to dispose or to direct the disposition of:

    0

     (iv) Shared power to dispose or to direct the disposition of:

    36248559

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    The Vanguard Group
     
    Signature:Ashley Grim
    Name/Title:Head of Global Fund Administration
    Date:03/05/2026
    Get the next $CME alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CME

    DatePrice TargetRatingAnalyst
    3/4/2026Buy → Hold
    Argus
    1/14/2026$305.00Hold → Buy
    TD Cowen
    10/23/2025$300.00Hold → Buy
    Deutsche Bank
    9/25/2025$300.00Neutral → Buy
    Citigroup
    7/24/2025$305.00Buy → Neutral
    UBS
    4/8/2025$301.00Equal-Weight → Overweight
    Morgan Stanley
    3/10/2025$287.00Mkt Perform → Outperform
    Raymond James
    1/6/2025$255.00 → $250.00Buy → Neutral
    Citigroup
    More analyst ratings

    $CME
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Shepard William R bought $73,008 worth of Common Stock Class A (262 units at $278.37), increasing direct ownership by 0.45% to 2,477 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    1/2/26 2:30:36 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Director Shepard William R bought $72,672 worth of Common Stock Class A (274 units at $265.19), increasing direct ownership by 0.47% to 2,466 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    9/26/25 8:46:02 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Director Shepard William R was granted 879 units of Common Stock Class A and bought $72,336 worth of Common Stock Class A (267 units at $270.53), increasing direct ownership by 0.46% to 2,455 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    6/26/25 6:11:41 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CME Group Reaches New Open Interest and Volume Records in Dairy Futures and Options

    CHICAGO, March 3, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its Dairy futures and options products set a new open interest (OI) record of 403,113 contracts on February 27. In addition, Dairy futures and options reached a new record monthly average daily volume (ADV) of 11,234 contracts in February. The previous ADV record was 9,514 contracts in September 2025.  "Tightening nonfat dry milk and butter inventories along with strong demand for whey protein have led clients to turn to CME Group in record numbers to manage their risk," said John Ricci, CME Group Managing Director and Global Head of Agricultural Products. "Our commitment to ou

    3/3/26 11:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Sets New Monthly ADV Record of 37.6 Million Contracts in February, Up 14% Year Over Year

    Record ADV in interest rate products, including U.S. Treasury futures and optionsRecord ADV in agricultural productsRecord international ADV of 11.6 million contractsCHICAGO, March 3, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its average daily volume (ADV) reached a new monthly record of 37.6 million contracts in February, an increase of 14% year-over-year. The company's previous monthly ADV record was set in April 2025 with 35.9 million contracts. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume. February 2026 ADV across asset classes includes:Interest Rate ADV of 21.3 million contractsEquit

    3/3/26 7:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Global Head of Commodities to Present at 2026 Raymond James Annual Institutional Investors Conference

    CHICAGO, Feb. 25, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that Derek Sammann, Senior Managing Director, Global Head of Commodities, will present at the 47th annual Raymond James Institutional Investors Conference on Tuesday, March 3, 2026, at 9:15 a.m. (Eastern Time). The presentation will be available for livestreaming via CME Group's Investor Relations website. Please allow extra time prior to the presentation to visit the site and download the streaming media software required to listen to the online broadcast. An audio webcast will be available for replay at the same address approximately 24 hours following the conclusion of the confer

    2/25/26 4:23:00 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Durkin Bryan T sold $1,300,530 worth of Common Stock Class A (4,200 units at $309.65), decreasing direct ownership by 9% to 43,007 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    2/23/26 4:46:37 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Director Gepsman Martin J sold $91,770 worth of Common Stock Class A (300 units at $305.90), decreasing direct ownership by 1% to 24,999 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    2/20/26 2:07:37 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Director Suskind Dennis sold $224,400 worth of Common Stock Class A (748 units at $300.00), decreasing direct ownership by 22% to 2,699 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    2/9/26 1:03:33 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CME Group downgraded by Argus

    Argus downgraded CME Group from Buy to Hold

    3/4/26 8:23:45 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group upgraded by TD Cowen with a new price target

    TD Cowen upgraded CME Group from Hold to Buy and set a new price target of $305.00

    1/14/26 8:20:33 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded CME Group from Hold to Buy and set a new price target of $300.00

    10/23/25 9:04:53 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by CME Group Inc.

    SCHEDULE 13G/A - CME GROUP INC. (0001156375) (Subject)

    3/5/26 1:24:32 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 10-K filed by CME Group Inc.

    10-K - CME GROUP INC. (0001156375) (Filer)

    2/26/26 5:30:26 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CME GROUP INC. (0001156375) (Filer)

    2/4/26 7:06:41 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/13/24 5:02:29 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/13/23 2:49:27 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/11/22 3:04:00 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Financials

    Live finance-specific insights

    View All

    CME Group Declares Annual Variable Dividend and Q1 2026 Quarterly Dividend

    CHICAGO, Feb. 12, 2026 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared its annual variable dividend and first-quarter regular dividend, both of which are payable March 26, 2026, to shareholders of record as of March 10, 2026: Annual variable dividend based on 2025 financial results of $6.15 per share totals approximately $2.2 billion.First-quarter regular dividend of $1.30 per share, a 5 cent increase from the prior level of $1.25 per share.Today's announced annual variable dividend based on 2025 financial results, when combined with quarterly dividends paid during 2025, will total approximately $4.0 billion, reflecting a total dividend yield of 4

    2/12/26 7:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. Reports Fourth Consecutive Year of Record Annual Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for 2025

    Record annual revenue of $6.5 billion, up 6%Record annual market data revenue of $803 million, up 13%CHICAGO, Feb. 4, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the fourth quarter and full year of 2025. The company reported revenue of $1.6 billion and operating income of $1.0 billion for the fourth quarter of 2025. Net income was $1.2 billion and diluted earnings per common share were $3.24. On an adjusted basis, net income was $1.0 billion and diluted earnings per common share were $2.77. Financial results presented on an adjusted basis for the fourth quarter of 2025 and 2024 exclude certain items, which are detailed in the reconciliation of non-G

    2/4/26 7:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. Announces Fourth-Quarter and Year-End 2025 Earnings Release, Conference Call

    CHICAGO, Dec. 17, 2025 /PRNewswire/ -- CME Group Inc. will announce earnings for the fourth quarter and full year of 2025 before the markets open on Wednesday, February 4, 2026. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions.  A live audio Webcast of the conference call will be available on the Investor Relations section of the company's website. Following the conference call, an archived recording will be available at the same site

    12/17/25 7:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Leadership Updates

    Live Leadership Updates

    View All

    Leading Financial Institutions to Join BrokerTec Chicago for First Day of Trading

    New Central Limit Order Book for U.S. Treasury Trading to Launch Oct. 6CHICAGO, Sept. 4, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that Citigroup, J.P. Morgan and Morgan Stanley will be available to trade cash U.S. Treasuries on BrokerTec Chicago when it launches on October 6. "With leading financial firms on board for day one on BrokerTec Chicago, trading U.S. Treasury futures and cash will be more efficient than ever before," said Mike Dennis, CME Group Global Head of Fixed Income. "CME Group is in a unique position to bring these markets together, unlocking value for our clients worldwide who want to more precisely hedge their risk amid

    9/4/25 8:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. Announces Preliminary Results from its 2025 Annual Meeting of Shareholders

    CHICAGO, May 9, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today announced the preliminary shareholder voting results from its 2025 annual meeting. At the meeting, shareholders: Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford Jr., Martin J. Gepsman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2026.Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2025.Approved, on an advisory basis, the compensation of our named executive officers.There was

    5/9/25 10:29:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Clearing Appoints New Chief Risk Officer

    CHICAGO, April 24, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the appointment of Vijay Albuquerque as Chief Risk Officer (CRO) in its Clearing & Post-Trade Services Division.  With over 20 years' industry experience, Albuquerque most recently served as the Head of Counterparty Risk and Portfolio Risk Analytics for Citigroup's Markets and Banking businesses. Albuquerque will be based in New York and will report to Suzanne Sprague, CME Group Chief Operating Officer and Global Head of Clearing. "Vijay's deep expertise in both derivatives and securities markets will be invaluable as we continue to deliver leading risk management services to our

    4/24/25 4:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance